Speaker Profile

Co-Founder and CEO, Phosphorous

Alexander Bisignano serves as the Chief Executive Officer for Phosphorus. Alex is responsible for long-term direction and development of Phosphorus diagnostic tests, software, and research initiatives. Before Phosphorus, Alex co-founded Recombine, a clinical genetic testing company, which was acquired by CooperSurgical in May of 2016. At Phosphorus and Recombine Alex helped develop novel genotyping and next-generation sequencing platforms for clinical genetics. His work has been presented at the American Society for Reproductive Medicine, the European Society for Human Reproduction and Embryology and a number of other scientific programs. Alex has also appeared on Fox Business and Bloomberg TV as an expert in the genetic testing market. Alex received his B.A. in molecular biology from Princeton University and is a member of Sigma Xi, the Scientific Research Society.

Session Abstract – PMWC 2018 Silicon Valley

Session Synopsis: As Next Generation Sequencing continues to outpace Moores Law it’s broad adoption in a clinical environment still faces several barriers to entry, namely complexity in workflow and reimbursement. To economically enable value based healthcare, technology providers need to think bigger and reimbursement needs to be more broadly understood and simplified. Come hear from our expert panelists about their thoughts on the current state of reimbursement, where things are moving and how individuals not directly involved in reimbursement can influence and expedite change.